GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Additional Paid-In Capital

Curocell (XKRX:372320) Additional Paid-In Capital : ₩174,368.79 Mil(As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Additional Paid-In Capital?


Curocell's quarterly additional paid-in capital increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩70,468.75 Mil) and increased from Dec. 2022 (₩70,468.75 Mil) to Jun. 2023 (₩174,368.79 Mil).

Curocell's annual additional paid-in capital increased from Dec. 2021 (₩70,427.23 Mil) to Dec. 2022 (₩70,468.75 Mil) and increased from Dec. 2022 (₩70,468.75 Mil) to Dec. 2023 (₩205,659.66 Mil).

Curocell Additional Paid-In Capital Historical Data

The historical data trend for Curocell's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Additional Paid-In Capital Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
355.06 38,713.03 70,427.23 70,468.75 205,659.66

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital - 70,468.75 174,368.79 205,659.66

Curocell Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Curocell Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Curocell's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Additional Paid-In Capital
Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Website
https://www.curocellbtx.com
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines